|
Home>News Center>Life | |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Top anti-depressant linked to increased suicide risk
LONDON (AFP) - One of Britain's most widely prescribed anti-depressant drugs -- Seroxat manufactured by British pharmaceuticals giant GlaxoSmithKline -- has been linked to a seven-fold increase in suicide attempts, a newspaper reported.
It said suicidal thoughts were three times more common among those taking Seroxat (paroxetine). Almost 2.4 million prescriptions for the drug were issued in England last year, the Times said. The study, published in the British medical magazine BMC Medicine and picked up by the Times on its front page, was carried out before Seroxat was first licenced in 1990. The Times said that several organisations, including the mental health charity Mind, have called for the drug to be withdrawn. It said that the company and the British Medicines and Healthcare products Regulatory Agency (MHRA) have defended the drug, saying its benefits outweigh the risks.
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
